1. Kaufmann, S. H. E. (ed.) (2004) Novel Vaccination Strategies. Wiley-VCH, Weinheim.
2. Huang, D. B., Wu, J. J., and Tyring, S. K. (2004) A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines. J. Infect.
49, 179–209.
3. Aunins, J. G. (2000) Viral vaccine production in cell culture, in Encyclopedia of Cell Technology (Stier, R. E., ed.), Wiley & Sons, New York, pp. 1182–1217.
4. Reichl, U. (2000) ISCOM vaccines—antigen production and downstream processing, in Proc. 4th Int. Congress on Biochemical Engineering, Fraunhofer IRB Verlag, Stuttgart, pp. 314–318.
5. Genzel, Y., Voges, L., and Reichl, U. (2001) Development of bioprocess concepts on vaccine production: influenza virus as an example, in Animal Cell Technology: From Target to Market (Lindner-Olsson, Chatzissavidou, N., and Lüllau, E., eds.), Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 344–346.